Regeneron Pharmaceuticals shares owned by Capital Research and Management Company - Division 3
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Capital Research and Management Company - Division 3
from 13F filings
Historical chart of Capital Research and Management Company - Division 3 investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Capital Research and Management Company - Division 3 consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Capital Research and Management Company - Division 3
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $493M | 877k | 562.25 |
| 2025-06-30 | $1.7B | 3.2M | 524.97 |
| 2025-03-31 | $2.5B | 4.0M | 634.27 |
| 2024-12-31 | $3.4B | 4.7M | 712.25 |
| 2024-09-30 | $3.5B | 3.3M | 1051.11 |
| 2024-03-31 | $3.0B | 3.1M | 962.49 |
| 2023-12-31 | $2.6B | 2.9M | 878.33 |
| 2023-09-30 | $2.4B | 3.0M | 823.06 |
| 2023-06-30 | $2.1B | 3.0M | 718.50 |
| 2023-03-31 | $1.8B | 2.2M | 821.67 |
| 2022-12-31 | $1.1B | 1.5M | 721.49 |
| 2022-03-31 | $1.2B | 1.7M | 698.42 |
| 2021-12-31 | $168M | 266k | 631.52 |
| 2021-09-30 | $685M | 1.1M | 605.18 |
| 2021-06-30 | $721M | 1.3M | 558.54 |
| 2021-03-31 | $610M | 1.3M | 473.14 |
| 2020-12-31 | $659M | 1.4M | 483.11 |
| 2020-09-30 | $808M | 1.4M | 559.78 |
| 2020-06-30 | $979M | 1.6M | 623.65 |
| 2020-03-31 | $792M | 1.6M | 488.29 |
| 2019-12-31 | $570M | 1.5M | 375.48 |
| 2019-09-30 | $421M | 1.5M | 277.40 |
| 2019-06-30 | $475M | 1.5M | 313.00 |
| 2019-03-31 | $648M | 1.6M | 410.62 |
| 2018-12-31 | $571M | 1.5M | 373.50 |
| 2018-09-30 | $703M | 1.7M | 404.04 |
| 2016-09-30 | $38M | 94k | 402.01 |
| 2016-06-30 | $33M | 93k | 349.23 |
| 2016-03-31 | $34M | 93k | 360.44 |
| 2015-12-31 | $51M | 93k | 542.87 |
| 2015-06-30 | $18k | 36 | 500.00 |
More positions owned by Capital Research and Management Company - Division 3
View all positions for Capital Research and Management Company - Division 3